Lytica Therapeutics
Cambridge, US · Founded 2019 · Delaware corporation
Find your way into Lytica Therapeutics
Sign up to see every warm intro you have to Lytica Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lytica Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RM
RIDA MOURTADANamed on SEC filing
Board
JL
JAMES LATORREBoard director
DM
DANIEL MACAYABoard director
JD
JEAN-FRANCOIS DUCRESTBoard director
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 3 rounds · 2024–2025
▶$6MraisedApr 2025 · 17 investors · BiotechnologyRule 506(b)
▶$6MraisedApr 2025 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JEAN-FRANCOIS DUCRESTDirector
- JAMES LATORREDirector
- DANIEL MACAYADirector
- RIDA MOURTADAExecutive Officer, Director
- Amount sold
- $6M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedAug 2024 · 9 investors · BiotechnologyRule 506(b)
▶$1.8MraisedAug 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES LATORREDirector
- DANIEL MACAYADirector
- RIDA MOURTADAExecutive Officer, Director
- JEAN-FRANCOIS DUCRESTDirector
- Amount sold
- $1.8M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$4.1MraisedMar 2024 · 14 investors · BiotechnologyRule 506(b)
▶$4.1MraisedMar 2024 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JEAN-FRANCOIS DUCRESTDirector
- DANIEL MACAYADirector
- RIDA MOURTADAExecutive Officer, Director
- JAMES LATORREExecutive Officer, Director
- Amount sold
- $4.1M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lytica Therapeutics raised?
- Lytica Therapeutics has disclosed $11.8M raised across 3 rounds.
- Where is Lytica Therapeutics headquartered?
- Lytica Therapeutics is headquartered in Cambridge, US.